|5.49||+0.305 / +5.89%|
As of 3:59pm ET
|5.49||+0.005 / +0.09%|
The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +27.62% increase from the last price of 5.49.
The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.